Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruben Bill

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Cell|March 31, 2023
A neutrophil response linked to tumor control in immunotherapyJeremy Gungabeesoon, Nicolas A Gort-Freitas, Máté Kiss, et al.
Journal for Immunotherapy of Cancer|May 19, 2023
Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunityLaura Fernandez-Rodriguez, Chiara Cianciaruso, Ruben Bill, et al.
Nature|December 5, 2022
Dendritic cells direct circadian anti-tumour immune responsesChen Wang, Coline Barnoud, Mara Cenerenti, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2020
Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapyAbhishek S Kashyap, Martina Schmittnaegel, Nicolò Rigamonti, et al.
Cancer Immunology Research|November 19, 2021
Macrophage-Targeted Therapy Unlocks Antitumoral Cross-talk between IFNγ-Secreting Lymphocytes and IL12-Producing Dendritic CellsChristina Pfirschke, Rapolas Zilionis, Camilla Engblom, et al.
Cell|May 9, 2024
Circadian tumor infiltration and function of CD8<sup>+</sup> T cells dictate immunotherapy efficacyChen Wang, Qun Zeng, Zeynep Melis Gül, et al.
Cancer Cell|February 6, 2026
CCL3 is produced by aged neutrophils across cancers and promotes tumor growthEvangelia Bolli, Pratyaksha Wirapati, Mehdi Hicham, et al.
Science (New York, N.Y.)|August 3, 2023
<i>CXCL9:SPP1</i> macrophage polarity identifies a network of cellular programs that control human cancersRuben Bill, Pratyaksha Wirapati, Marius Messemaker, et al.
Science Immunology|July 3, 2021
Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapyMarie Siwicki, Nicolas A Gort-Freitas, Marius Messemaker, et al.
Immunity|December 20, 2025
Positioning and reversible suppression of CCR7<sup>+</sup> dendritic cells in perivascular tumor niches shape cancer immunityBeatrice Zitti, Florent Duval, Pratyaksha Wirapati, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cell|March 31, 2023
A neutrophil response linked to tumor control in immunotherapyJeremy Gungabeesoon, Nicolas A Gort-Freitas, Máté Kiss, et al.
Journal for Immunotherapy of Cancer|May 19, 2023
Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunityLaura Fernandez-Rodriguez, Chiara Cianciaruso, Ruben Bill, et al.
Nature|December 5, 2022
Dendritic cells direct circadian anti-tumour immune responsesChen Wang, Coline Barnoud, Mara Cenerenti, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2020
Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapyAbhishek S Kashyap, Martina Schmittnaegel, Nicolò Rigamonti, et al.
Cancer Immunology Research|November 19, 2021
Macrophage-Targeted Therapy Unlocks Antitumoral Cross-talk between IFNγ-Secreting Lymphocytes and IL12-Producing Dendritic CellsChristina Pfirschke, Rapolas Zilionis, Camilla Engblom, et al.
Cell|May 9, 2024
Circadian tumor infiltration and function of CD8<sup>+</sup> T cells dictate immunotherapy efficacyChen Wang, Qun Zeng, Zeynep Melis Gül, et al.
Cancer Cell|February 6, 2026
CCL3 is produced by aged neutrophils across cancers and promotes tumor growthEvangelia Bolli, Pratyaksha Wirapati, Mehdi Hicham, et al.
Science (New York, N.Y.)|August 3, 2023
<i>CXCL9:SPP1</i> macrophage polarity identifies a network of cellular programs that control human cancersRuben Bill, Pratyaksha Wirapati, Marius Messemaker, et al.
Science Immunology|July 3, 2021
Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapyMarie Siwicki, Nicolas A Gort-Freitas, Marius Messemaker, et al.
Immunity|December 20, 2025
Positioning and reversible suppression of CCR7<sup>+</sup> dendritic cells in perivascular tumor niches shape cancer immunityBeatrice Zitti, Florent Duval, Pratyaksha Wirapati, et al.
Pageof 3